Stacked Autoencoder Based Multi-Omics Data Integration for Cancer Survival Prediction

Xing Wu, Qiulian FangarXiv 2022 · DOI · arXiv

TL;DR

Researchers have developed SAEsurv-net, a deep learning framework that integrates multiple types of biological data (multi-omics) to predict cancer survival. By using a two-stage dimensionality reduction strategy and stacked autoencoders, the model successfully navigates the "curse of dimensionality" to outperform single-data models and current state-of-the-art survival prediction tools.

What Problem Does This Paper Address?

Predicting how long a cancer patient might survive is a cornerstone of personalized medicine. However, cancer is a multi-level biological "glitch" occurring across genomes, transcriptomes, and proteomes. While we have massive amounts of "multi-omics" data (like gene expression and DNA copy numbers), using it effectively is incredibly difficult due to two main hurdles:

  1. The Curse of Dimensionality: Omics datasets often have tens of thousands of features (genes) but only a few hundred samples (patients). This leads to massive overfitting, where a model "memorizes" the training data instead of learning general patterns.
  2. Data Heterogeneity: Different types of data have different scales, distributions, and sizes. Trying to "mash" gene expression data together with clinical records is like trying to assemble a puzzle using pieces from three different boxes.

Existing methods often struggle to balance computational efficiency with the need to capture the complex, non-linear interactions between these different biological layers.

Methods

The authors propose SAEsurv-net (Stacked AutoEncoder-based Survival Prediction Neural Network), which uses a sophisticated two-stage approach:

  • Stage 1: Statistical Filtering: To combat the curse of dimensionality, they first prune the data. They remove features with zero variance and use log-rank tests to discard any features that don't show a statistically significant relationship with survival (p > 0.05). This reduces the feature count by over 90% before deep learning even begins.
  • Stage 2: Stacked Autoencoders (SAE):
    • Feature Extraction: The model feeds the filtered gene expression and copy number variation (CNV) data into separate, parallel autoencoders. These act as "compressors," translating high-dimensional data into a compact, non-linear latent representation.
  • Integration: These latent representations are then concatenated and fed into a second autoencoder. This "middle-ground" integration step removes the remaining heterogeneity between data types.
  • Risk Prediction: Finally, the integrated omics features are combined with clinical data and passed through a risk prediction network. This network uses a Cox proportional hazards model to output a Prognostic Index (PI), representing the patient's death risk.

Datasets

The model was evaluated using data from The Cancer Genome Atlas (TCGA), specifically focusing on three types of cancer:

  • GBM: Glioblastoma multiforme (156 samples).
  • OV: Ovarian serous cystadenocarcinoma (373 samples).
  • BRCA: Breast invasive carcinoma (1,040 samples).

Each dataset included three categories of information: gene expression (mRNA), copy number variations (CNV), and clinical data (age, gender, stage, etc.).

Key Insights and Ideas

  • The Power of "Middle" Integration: Unlike "early integration" (concatenating raw data) or "late integration" (averaging model outputs), SAEsurv-net uses an intermediate approach. By transforming data into a shared latent space first, it captures cross-omics interactions that simpler models miss.
  • Autoencoders as Translators: The first layer of autoencoders effectively "standardizes" the data. It strips away the noise inherent in different measurement technologies, allowing the integration layer to focus on the underlying biological signals.
  • Balancing Complexity: The two-stage reduction strategy is a pragmatic "aha moment." It acknowledges that while deep learning is powerful, it still needs a helping hand from traditional statistics to handle the extreme sparsity of medical data.

Key Results

The performance was measured using the C-index (concordance index), where 1.0 is a perfect prediction and 0.5 is random chance.

  • Superior Accuracy: SAEsurv-net consistently outperformed models based on a single data type (AE-gene or AE-cnv) and the popular DeepSurv algorithm.
  • For GBM, it achieved a mean C-index of 0.6212.
  • For BRCA, it reached 0.6451.
  • Risk Stratification: Using Kaplan-Meier plots, the researchers showed that the model could clearly separate patients into "high-risk" and "low-risk" groups with high statistical significance (p < 0.01 across all three cancers). This demonstrates the model's potential utility in a clinical setting to help doctors identify patients needing more aggressive intervention.

Limitations and Future Work

Despite the promising results, the authors highlight several areas for improvement:

  • Sample Size: Even with 1,000 samples (BRCA), the data is small relative to the number of parameters in a deep neural network.
  • The "Black Box" Problem: Like most deep learning models, SAEsurv-net lacks transparency. It’s hard for a clinician to see which specific biological pathway led to a high-risk score.
  • Future Directions: The authors suggest using transfer learning (training on unlabeled data first) and incorporating biological priors (like known gene-pathway interactions) to make the model more interpreable and robust against overfitting.

Summary updated

Abstract

Cancer survival prediction is important for developing personalized treatments and inducing disease-causing mechanisms. Multi-omics data integration is attracting widespread interest in cancer research for providing information for understanding cancer progression at multiple genetic levels. Many works, however, are limited because of the high dimensionality and heterogeneity of multi-omics data. In this paper, we propose a novel method to integrate multi-omics data for cancer survival prediction, called Stacked AutoEncoder-based Survival Prediction Neural Network (SAEsurv-net). In the cancer survival prediction for TCGA cases, SAEsurv-net addresses the curse of dimensionality with a two-stage dimensionality reduction strategy and handles multi-omics heterogeneity with a stacked autoencoder model. The two-stage dimensionality reduction strategy achieves a balance between computation complexity and information exploiting. The stacked autoencoder model removes most heterogeneities such as data's type and size in the first group of autoencoders, and integrates multiple omics data in the second autoencoder. The experiments show that SAEsurv-net outperforms models based on a single type of data as well as other state-of-the-art methods.
BibTeX
@misc{wu2022stacked,
  author = {Xing Wu and Qiulian Fang},
  title = {{Stacked Autoencoder Based Multi-Omics Data Integration for Cancer Survival Prediction}},
  year = {2022},
  eprint = {2207.04878},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2207.04878},
}
Figure